Henry v. Angelini Pharms, Inc., et al.,

Filing 15

ORDER signed by District Judge Troy L. Nunley on 1/31/18, ORDERING that Teva Pharmaceuticals USA, Inc., may have an extension of 28 days, until 2/13/2018, to respond to Plaintiff's Complaint. (Kastilahn, A)

1
2
3
4
5

KATHLEEN M. RHOADS (SBN: 144466)
GORDON REES SCULLY MANSUKHANI, LLP
655 University Avenue, Suite 200
Sacramento, CA 95825
Telephone: [phone]
Facsimile: [phone]
Email: [e-mail]
Attorneys for Defendant
TEVA PHARMACEUTICALS USA, INC.

6
7
8

UNITED STATES DISTRICT COURT

9

EASTERN DISTRICT OF CALIFORNIA

Gordon Rees Scully Mansukhani, LLP
655 University Avenue, Suite 200
Sacramento, CA 95825

10
11
12
13
14
15
16
17
18

TOBY HENRY,

)
)
Plaintiff,
)
)
vs.
)
)
ANGELINI PHARMA INC., ANGELINI,
)
ANGELINI LABOPHARM LLC, ENDO,
)
ENDO HEALTH SOLUTIONS, INC., ENDO )
INTERNATIONAL PLC, ENDO
)
PHARMACEUTICALS, INC., GRUPPO
)
ANGELINI, LABOPHARM INC.,
)
LABOPHARM USA, INC., PALADIN LABS )
INC., TEVA PHARMACEUTICALS USA,
)
INC., and DOES 1 through 100,
)
)
Defendants.
)
)

CASE NO. 2:17-cv-02593-TLN-KJN
ORDER GRANTING STIPULATION
EXTENDING DEADLINE FOR
DEFENDANT TEVA
PHARMACEUTICALS USA, INC. TO
RESPOND TO PLAINTIFF’S
COMPLAINT

19
20

Based upon the Stipulation Extending Deadline for Defendant Teva Pharmaceuticals

21

USA, Inc. to Respond to Plaintiffs’ Complaint filed on January 12, 2018 (Docket No. 8), and

22

good cause appearing,

23

IT IS HEREBY ORDERED that Teva Pharmaceuticals USA, Inc. may have an

24

extension of twenty-eight (28) days, until February 13, 2018, to respond to Plaintiff’s Complaint.

25

IT IS SO ORDERED.

26

Dated: 1/31/2018

27
28

Troy L. Nunley
United States District Judge

-1Order Granting Stipulation Extending Deadline For Defendant Teva Pharmaceuticals USA, Inc.
to Respond to Plaintiff’s Complaint
2:17-cv-2593-TLN-KJN